Catalase deficiency may complicate urate oxidase (rasburicase) therapy

L. Góth, N. William Bigler

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Patients with low (inherited and acquired) catalase activities who are treated with infusion of uric acid oxidase because they are at risk of tumour lysis syndrome may experience very high concentrations of hydrogen peroxide. They may suffer from methemoglobinaemia and haemolytic anaemia which may be attributed either to deficiency of glucose-6-phosphate dehydrogenase or to other unknown circumstances. Data have not been reported from catalase deficient patients who were treated with uric acid oxidase. It may be hypothesized that their decreased blood catalase could lead to the increased concentration of hydrogen peroxide which may cause haemolysis and formation of methemoglobin. Blood catalase activity should be measured for patients at risk of tumour lysis syndrome prior to uric acid oxidase treatment.

Original languageEnglish
Pages (from-to)953-955
Number of pages3
JournalFree Radical Research
Volume41
Issue number9
DOIs
Publication statusPublished - 2007

Fingerprint

Acatalasia
Urate Oxidase
Catalase
Uric Acid
Tumor Lysis Syndrome
Oxidoreductases
Hydrogen Peroxide
Tumors
Blood
Methemoglobinemia
Glucosephosphate Dehydrogenase Deficiency
Methemoglobin
Glucosephosphate Dehydrogenase
Hemolytic Anemia
Therapeutics
Hemolysis
rasburicase

Keywords

  • Blood catalase
  • Catalase deficiency
  • Haemolysis
  • Tumour lysis syndrome
  • Urate acid oxidase treatment

ASJC Scopus subject areas

  • Biochemistry

Cite this

Catalase deficiency may complicate urate oxidase (rasburicase) therapy. / Góth, L.; Bigler, N. William.

In: Free Radical Research, Vol. 41, No. 9, 2007, p. 953-955.

Research output: Contribution to journalArticle

Góth, L. ; Bigler, N. William. / Catalase deficiency may complicate urate oxidase (rasburicase) therapy. In: Free Radical Research. 2007 ; Vol. 41, No. 9. pp. 953-955.
@article{29e3e524c35d401eacde7b632a648ee8,
title = "Catalase deficiency may complicate urate oxidase (rasburicase) therapy",
abstract = "Patients with low (inherited and acquired) catalase activities who are treated with infusion of uric acid oxidase because they are at risk of tumour lysis syndrome may experience very high concentrations of hydrogen peroxide. They may suffer from methemoglobinaemia and haemolytic anaemia which may be attributed either to deficiency of glucose-6-phosphate dehydrogenase or to other unknown circumstances. Data have not been reported from catalase deficient patients who were treated with uric acid oxidase. It may be hypothesized that their decreased blood catalase could lead to the increased concentration of hydrogen peroxide which may cause haemolysis and formation of methemoglobin. Blood catalase activity should be measured for patients at risk of tumour lysis syndrome prior to uric acid oxidase treatment.",
keywords = "Blood catalase, Catalase deficiency, Haemolysis, Tumour lysis syndrome, Urate acid oxidase treatment",
author = "L. G{\'o}th and Bigler, {N. William}",
year = "2007",
doi = "10.1080/10715760701482451",
language = "English",
volume = "41",
pages = "953--955",
journal = "Free Radical Research",
issn = "1071-5762",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Catalase deficiency may complicate urate oxidase (rasburicase) therapy

AU - Góth, L.

AU - Bigler, N. William

PY - 2007

Y1 - 2007

N2 - Patients with low (inherited and acquired) catalase activities who are treated with infusion of uric acid oxidase because they are at risk of tumour lysis syndrome may experience very high concentrations of hydrogen peroxide. They may suffer from methemoglobinaemia and haemolytic anaemia which may be attributed either to deficiency of glucose-6-phosphate dehydrogenase or to other unknown circumstances. Data have not been reported from catalase deficient patients who were treated with uric acid oxidase. It may be hypothesized that their decreased blood catalase could lead to the increased concentration of hydrogen peroxide which may cause haemolysis and formation of methemoglobin. Blood catalase activity should be measured for patients at risk of tumour lysis syndrome prior to uric acid oxidase treatment.

AB - Patients with low (inherited and acquired) catalase activities who are treated with infusion of uric acid oxidase because they are at risk of tumour lysis syndrome may experience very high concentrations of hydrogen peroxide. They may suffer from methemoglobinaemia and haemolytic anaemia which may be attributed either to deficiency of glucose-6-phosphate dehydrogenase or to other unknown circumstances. Data have not been reported from catalase deficient patients who were treated with uric acid oxidase. It may be hypothesized that their decreased blood catalase could lead to the increased concentration of hydrogen peroxide which may cause haemolysis and formation of methemoglobin. Blood catalase activity should be measured for patients at risk of tumour lysis syndrome prior to uric acid oxidase treatment.

KW - Blood catalase

KW - Catalase deficiency

KW - Haemolysis

KW - Tumour lysis syndrome

KW - Urate acid oxidase treatment

UR - http://www.scopus.com/inward/record.url?scp=34548348331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548348331&partnerID=8YFLogxK

U2 - 10.1080/10715760701482451

DO - 10.1080/10715760701482451

M3 - Article

C2 - 17729111

AN - SCOPUS:34548348331

VL - 41

SP - 953

EP - 955

JO - Free Radical Research

JF - Free Radical Research

SN - 1071-5762

IS - 9

ER -